These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10902101)

  • 21. Blocking aldosterone in heart failure.
    Shafiq MM; Miller AB
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy.
    Remme WJ
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):349-60. PubMed ID: 14618097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocyte changes in heart failure.
    Savinova OV; Gerdes AM
    Heart Fail Clin; 2012 Jan; 8(1):1-6. PubMed ID: 22108722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current concepts and pharmacologic treatment of heart failure.
    Capriotti T
    Medsurg Nurs; 2002 Apr; 11(2):71-83; quiz 84. PubMed ID: 11962171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.
    Shah AM; Mann DL
    Lancet; 2011 Aug; 378(9792):704-12. PubMed ID: 21856484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of apoptosis in ventricular remodeling.
    Chandrashekhar Y
    Curr Heart Fail Rep; 2005 Mar; 2(1):18-22. PubMed ID: 16036047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pacemaker therapy in refractory heart failure: a systematic approach to electromechanical optimization of diastolic function.
    Marcus RH; Harry MJ; Lang RM
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):908-13. PubMed ID: 19608142
    [No Abstract]   [Full Text] [Related]  

  • 28. Ventricular remodeling in heart failure.
    Gaballa MA; Goldman S
    J Card Fail; 2002 Dec; 8(6 Suppl):S476-85. PubMed ID: 12555161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connective tissue and the heart. Functional significance and regulatory mechanisms.
    Burlew BS; Weber KT
    Cardiol Clin; 2000 Aug; 18(3):435-42. PubMed ID: 10986582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective.
    Bradham WS; Bozkurt B; Gunasinghe H; Mann D; Spinale FG
    Cardiovasc Res; 2002 Mar; 53(4):822-30. PubMed ID: 11922892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure.
    Weber KT; Díez J
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27470499
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.
    Edgley AJ; Krum H; Kelly DJ
    Cardiovasc Ther; 2012 Feb; 30(1):e30-40. PubMed ID: 21883991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies.
    Takano H; Hasegawa H; Nagai T; Komuro I
    Intern Med; 2003 Jun; 42(6):465-9. PubMed ID: 12857042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocyte apoptosis in heart failure.
    van Empel VP; Bertrand AT; Hofstra L; Crijns HJ; Doevendans PA; De Windt LJ
    Cardiovasc Res; 2005 Jul; 67(1):21-9. PubMed ID: 15896727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A look between the cardiomyocytes: the extracellular matrix in heart failure.
    Miner EC; Miller WL
    Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
    Orea-Tejeda A; Colín-Ramírez E; Castillo-Martínez L; Asensio-Lafuente E; Corzo-León D; González-Toledo R; Rebollar-González V; Narváez-David R; Dorantes-García J
    Rev Invest Clin; 2007; 59(2):103-7. PubMed ID: 17633796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioreparation in hypertensive heart disease.
    Weber KT
    Hypertension; 2001 Sep; 38(3 Pt 2):588-91. PubMed ID: 11566936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting histone deacetylases for heart failure.
    Bush EW; McKinsey TA
    Expert Opin Ther Targets; 2009 Jul; 13(7):767-84. PubMed ID: 19466913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New therapeutics for chronic heart failure.
    Mann DL; Deswal A; Bozkurt B; Torre-Amione G
    Annu Rev Med; 2002; 53():59-74. PubMed ID: 11818463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New therapeutic options in congestive heart failure: Part I.
    McMurray J; Pfeffer MA
    Circulation; 2002 Apr; 105(17):2099-106. PubMed ID: 11980691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.